Guggenheim Capital LLC Phibro Animal Health Corp Transaction History

Guggenheim Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$31.18 - $44.64 $276,410 - $395,733	-8,865 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$42.3 - $53.5 $87,899 - $111,173	2,078 Added 30.62%	8,865 $380,000
Q2 2018 Aug 14, 2018	SELL	$38.7 - $48.1 $1 Million - $1.25 Million	-25,945 Reduced 79.26%	6,787 $313,000
Q1 2018 May 15, 2018	BUY	$32.2 - $40.45 $2,447 - $3,074	76 Added 0.23%	32,732 $1.3 Million
Q4 2017 Feb 14, 2018	BUY	$32.65 - $37.9 $1.07 Million - $1.24 Million	32,656	32,656 $1.1 Million

148

20.4M

Ticker PAHC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,337,600
Market Cap $441M
Description
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.